Gail Maderis

Gail Maderis

Chairman at DURECT CORPORATION

Net worth: 48 400 $ as of 31/03/2024

66 year
Health Technology
Commercial Services
Consumer Services

Network origin in Gail Maderis first degree

EntityEntity typeIndustry
220
Non-Profit Organization Miscellaneous Commercial Services 220
Harvard Business School
103
College/University Other Consumer Services 103
34
Non-Profit Organization Miscellaneous Commercial Services 34
Public Company Pharmaceuticals: Major 29
25
Foundation/Endowment Investment Trusts/Mutual Funds 25
21
Extinct Pharmaceuticals: Major 21
Public Company Pharmaceuticals: Major 19
15
Non-Profit Organization Miscellaneous Commercial Services 15
10
Holding Company Biotechnology 10
Subsidiary Biotechnology 9
The Bay Area Bioscience Association
7
Extinct Biotechnology 7
Public Company Pharmaceuticals: Major 7
7
Private Company Pharmaceuticals: Major 7
Termeer Foundation
4
Private Company 4
4
Holding Company Biotechnology 4

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Gail Maderis via their personal network

CompanySectorRelated peopleMain position
Pharmaceuticals: Major

Richard Pops

Mark B. Skaletsky

Chief Executive Officer

Director/Board Member

ALZA CORPORATION Pharmaceuticals: Major

James Brown

David Hoffmann

John Orwin

Chief Tech/Sci/R&D Officer

Director of Finance/CFO

Sales & Marketing

AMGEN INC. Pharmaceuticals: Major

Fabrizio Bonanni

Helen Torley

Terry Rosen

Peter García

Michael Severino

Chief Operating Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Biotechnology

Mark B. Skaletsky

John Maraganore

President

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Helen Torley

Jeremy Levin

N. Coles

Mike Raab Raab

James Sapirstein

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Biotechnology

Ted Love

John Orwin

Martin Babler

Jeffrey Jonker

General Counsel

Corporate Officer/Principal

Sales & Marketing

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

Edward O. Lanphier

Thomas Wiggans

Jan Lundberg

James Sapirstein

Martin Babler

Corporate Officer/Principal

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Chief Operating Officer

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Gerald McLaughlin

N. Coles

Donald P. Beeman

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Frederick Telling

Joseph Damond

Gail Farfel

Albert Bourla

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

Chief Executive Officer

ASTRAZENECA PLC Pharmaceuticals: Major

David Mott

Jan Lundberg

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Deborah Dunsire

Steven Holtzman

John Maraganore

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Helen Torley

Ted Love

Thomas Wiggans

N. Coles

Chief Operating Officer

Chief Tech/Sci/R&D Officer

Director/Board Member

Chief Executive Officer

Pharmaceuticals: Major

Helen Torley

Judith Robertson

Chief Tech/Sci/R&D Officer

Sales & Marketing

LEXICON PHARMACEUTICALS, INC. Pharmaceuticals: Major

Arthur Sands

Julia Gregory

Founder

Director of Finance/CFO

MONSANTO Wholesale Distributors

Hugh Grant

Barbara H. Wells

Charles Eggert

Chief Executive Officer

Corporate Officer/Principal

Corporate Officer/Principal

SEAGEN INC. Pharmaceuticals: Major

Ted Love

Clay Siegall

John Orwin

Director/Board Member

Chief Executive Officer

Director/Board Member

Medical Specialties

Marc Beer

Alan Walts

Mike Raab Raab

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

AMICUS THERAPEUTICS, INC. Pharmaceuticals: Major

Ted Love

Mike Raab Raab

Mike C. Diem

Director/Board Member

Chairman

Corporate Officer/Principal

AMYRIS, INC. Chemicals: Specialty

John Melo

Jason Raleigh

Chief Executive Officer

Corporate Officer/Principal

Pharmaceuticals: Major

David Mott

Mike Raab Raab

Director/Board Member

Director/Board Member

SHIRE Pharmaceuticals: Major

David Mott

Flemming Ørnskov

Director/Board Member

Chief Executive Officer

NURIX THERAPEUTICS, INC. Pharmaceuticals: Major

Arthur Sands

Julia Gregory

Clay Siegall

Chief Executive Officer

Director/Board Member

Director/Board Member

NOVARTIS AG Pharmaceuticals: Major

David Pyott

Deborah Dunsire

Flemming Ørnskov

Royston Glasspool

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Dartmouth College College/University

David Mott

Thomas B. Okarma

Undergraduate Degree

Undergraduate Degree

College/University

N. Coles

Steven D. Singer

Swan Sit

Graduate Degree

Graduate Degree

Undergraduate Degree

Stanford University College/University

Richard Pops

Thomas B. Okarma

Peter García

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

University of Glasgow College/University

Helen Torley

Hugh Grant

Undergraduate Degree

Undergraduate Degree

Investment Managers

David Mott

Mike Raab Raab

Private Equity Investor

Private Equity Investor

INFINITY PHARMACEUTICALS, INC. Pharmaceuticals: Major

Steven Holtzman

Martin Babler

Founder

Director/Board Member

Rutgers State University of New Jersey College/University

Mike C. Diem

John Orwin

James Sapirstein

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Yale University College/University

Arthur Sands

Christopher G. Standlee

Undergraduate Degree

Undergraduate Degree

Oregon State University College/University

Barbara H. Wells

Jay T. Evans

Doctorate Degree

Graduate Degree

Princeton University College/University

Carl Feldbaum

Ronald Cohen

Joseph Damond

Undergraduate Degree

Undergraduate Degree

Graduate Degree

University of California, Berkeley College/University

Terry Rosen

David J. Ellis

Doctorate Degree

Doctorate Degree

University of Kansas College/University

Christopher G. Standlee

Thomas Wiggans

Graduate Degree

Undergraduate Degree

Georgetown University College/University

Steven Holtzman

Joseph Damond

Director/Board Member

Undergraduate Degree

Pharmaceuticals: Major

Patrick Zenner

Deborah Dunsire

Richard Pops

Joseph Damond

Albert Bourla

Director/Board Member

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Chairman

Miscellaneous Commercial Services

Carl Feldbaum

Jeremy Levin

Edward O. Lanphier

Ted Love

Thomas Wiggans

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Chairman

Miscellaneous Commercial Services

Jeremy Levin

Joel Marcus

Ronald Cohen

Director/Board Member

Director/Board Member

Chairman

Miscellaneous Commercial Services

Joel Marcus

Michael H. Bison

Steven D. Singer

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

RELYPSA INC Pharmaceuticals: Major

Helen Torley

John Orwin

Director/Board Member

Chief Executive Officer

ARDELYX, INC. Pharmaceuticals: Major

David Mott

Jan Lundberg

Mike Raab Raab

Chairman

Director/Board Member

Chief Executive Officer

Harvard Medical School College/University

Richard Pops

N. Coles

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

John Nicols

Terry Rosen

Mike Raab Raab

John Melo

Director/Board Member

Director/Board Member

Director/Board Member

Director/Board Member

Baybio Institute

John Melo

Jeffrey Peterson

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Jeremy Levin

Jean-Francois Formela

Director/Board Member

Director/Board Member

Statistics

International

United States 45
United Kingdom 3
Ireland 2
Switzerland 2
France 2

Sectoral

Health Technology 31
Consumer Services 13
Commercial Services 5
Distribution Services 2
Process Industries 2

Operational

Director/Board Member 736
Corporate Officer/Principal 242
Chairman 179
Independent Dir/Board Member 179
Chief Executive Officer 161
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW